Skip to main content
placeholder image

610 Loss of the Tumor Suppressor Merlin as a Potential Predictive Biomarker of Clinical Activity for the Oral, Focal Adhesion Kinase (FAK) Inhibitor GSK2256098 in Pts with Recurrent Mesothelioma

Journal Article


Abstract


UOW Authors


  •   Ranson, Marie (external author)

Publication Date


  • 2012

Citation


  • Soria, J. C., Plummer, R., Ranson, M., Gan, H., Arkenau, H. T., Zalcman, G., . . . Millward, M. (2012). 610 Loss of the Tumor Suppressor Merlin as a Potential Predictive Biomarker of Clinical Activity for the Oral, Focal Adhesion Kinase (FAK) Inhibitor GSK2256098 in Pts with Recurrent Mesothelioma. European Journal of Cancer, 48, 188. doi:10.1016/s0959-8049(12)72407-3

Web Of Science Accession Number


Start Page


  • 188

Volume


  • 48

Abstract


UOW Authors


  •   Ranson, Marie (external author)

Publication Date


  • 2012

Citation


  • Soria, J. C., Plummer, R., Ranson, M., Gan, H., Arkenau, H. T., Zalcman, G., . . . Millward, M. (2012). 610 Loss of the Tumor Suppressor Merlin as a Potential Predictive Biomarker of Clinical Activity for the Oral, Focal Adhesion Kinase (FAK) Inhibitor GSK2256098 in Pts with Recurrent Mesothelioma. European Journal of Cancer, 48, 188. doi:10.1016/s0959-8049(12)72407-3

Web Of Science Accession Number


Start Page


  • 188

Volume


  • 48